Hyperbaric oxygen inhibits ischemia-reperfusion-induced neutrophil CD18 polarization by a nitric oxide mechanism

Plastic and Reconstructive Surgery

Volumn 126, Issue 2, 2010, Pages 403-411

  Jones, Seth R ^a   Carpin, Kimberly M ^a   Woodward, Stephanie M ^a   Khiabani, Kayvan T ^a   Stephenson, Linda L ^a   Wang, Wei Z ^a   Zamboni, William A ^a,b  

^a University of Nevada School of Medicine   (United States)

^b UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD18 ANTIGEN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; CELL ADHESION; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; HYPERBARIC OXYGEN; MALE; METABOLISM; METHODOLOGY; NEUTROPHIL; POLARIZATION MICROSCOPY; PROBABILITY; RANDOMIZATION; RAT; REPERFUSION INJURY; SKELETAL MUSCLE; VASCULARIZATION; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD18; CELL ADHESION; DISEASE MODELS, ANIMAL; HYPERBARIC OXYGENATION; MALE; MICROSCOPY, POLARIZATION; MUSCLE, SKELETAL; NEUTROPHILS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROBABILITY; RANDOM ALLOCATION; RATS; RATS, WISTAR; REPERFUSION INJURY;

EID: 77955400655     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3181df64a5     Document Type: Article

References (44)

1. Sterling DL, Thornton JD, Swafford A, et al. Hyperbaric oxygen limits infarct size in ischemic rabbit myocardium in vivo. Circulation 1993;88:1931-1936.
2. Cabigas BP, Su J, Hutchins W, et al. Hyperoxic and hyperbaric- induced cardioprotection: Role of nitric oxide synthase. Cardiovasc Res. 2006;72:143-151.
3. Helms AK, Whelan HT, Torbey MT. Hyperbaric oxygen therapy of cerebral ischemia. Cerebrovasc Dis. 2005;20:417-426.
4. Wong HP, Zamboni WA, Stephenson LL. Effect of hyperbaric oxygen on skeletal muscle necrosis following primary and secondary ischemia in a rat model. Surg Forum 1996; XLVII:705-707.
5. Allen DM, Chen L, Seaber AV, Urbaniak JR. Pathophysiology and related studies of no reflow phenomenon in skeletal muscle. Clin Orthop Relat Res. 1995;314:122-133.
6. Zamboni WA, Roth AC, Russell RC, Graham B, Suchy H, Kucan JO. Morphologic analysis of the microcirculation during reperfusion of ischemic skeletal muscle and the effect of hyperbaric oxygen. Plast Reconstr Surg. 1998;91:1111-1121.
7. Angel MF, Ramasastry SS, Swartz WM, Basford RE, Futrell JW. Free radicals: Basic concepts concerning their chemistry, pathophysiology, and relevance to plastic surgery. Plast Reconstr Surg. 1987;79:990-997.
8. Russell RC, Roth AC, Kucan JO, Zook EG. Reperfusion injury and oxygen free radicals: A review. J Reconstr Microsurg. 1989; 5:79-84.
9. Inauen W, Suzuki M, Granger DN. Mechanisms of cellular injury: Potential source of oxygen free radicals in ischemia/ reperfusion. Microcirc Endothelium Lymphatics 1989;5:143-155.
10. Pang CY. Ischemia-induced reperfusion injury in muscle flaps: Pathogenesis and major source of free radicals. J Reconstr Microsurg. 1990;6:77-83.
11. Zamboni WA, Stephenson LL, Roth AC, Suchy H, Russell RC. Ischemia-reperfusion injury in skeletal muscle: CD18-dependent neutrophil-endothelial adhesion and arteriolar vasoconstriction. Plast Reconstr Surg. 1997;99:2002-2007; discussion 2008-2009.
12. Larson JL, Stephenson LL, Zamboni WA. Effect of hyperbaric oxygen on neutrophil CD18 expression. Plast Reconstr Surg. 2000;105:1375-1381.
13. Khiabani KT, Stephenson LL, Gabriel A, Nataraj C, Wang WZ, Zamboni WA. A quantitative method for determining polarization of neutrophil adhesion molecules associated with ischemia reperfusion. Plast Reconstr Surg. 2004;114:1846-1850.
14. Anderson SI, Hotchin NA, Nash GB. Role of the cytoskeleton in rapid activation of CD11b/CD18 function and its subsequent down regulation in neutrophils. J Cell Sci. 2000;113: 2737-2745.
15. Haverstick DM, Sakai H, Gray LS. Lymphocyte adhesion can be regulated by cytoskeleton-associated, PMN-induced capping of surface receptors. Am J Physiol. 1992;262:C916-C926.
16. Tohya K, Kimura M. Ultrastructural evidence of distinctive behavior of L-selectin and LFA-1 (alphaLbeta2 integrin) on lymphocytes adhering to the endothelial surface of high endothelial venules in peripheral lymph nodes. Histochem Cell Biol. 1998;110:407-416.
17. Strauss MB, Hargens AR, Gershuni DH, et al. Reduction of skeletal muscle necrosis using intermittent hyperbaric oxygen in a model compartment syndrome. J Bone Joint Surg (Am.) 1983;65:656-662.
18. Nylander G, Lewis D, Nordstrom H, Larson J. Reduction of postischemic edema with hyperbaric oxygen. Plast Reconstr Surg. 1985;76:596-603.
19. Skyhar MJ, Hargens AR, Strauss MB, Gershuni DH, Hart GB, Akeson WH. Hyperbaric oxygen reduces edema and necrosis of skeletal muscle in compartment syndromes associated with hemorrhagic hypotension. J Bone Joint Surg (Am.) 1986; 68:1218-1224.
20. Khiabani KT, Bellister SR, Skaggs SS, Stephenson LL, Wang WZ, Zamboni WA. Reperfusion induced neutrophil CD18 polarization: Effect of hyperbaric oxygen. J Surg Res. 2008; 150:11-16.
21. Meldrum DG, Stephenson LL, Zamboni A. Effects of L-NAME and L-arginine on ischemia-reperfusion injury in rat skeletal muscle. Plast Reconstr Surg. 1999;103:935-940.
22. Gabriel A, Stephenson LL, Zamboni WA. Effect of L-arginine on leukocyte adhesion in ischemia-reperfusion injury. Plast Reconstr Surg. 2004;113:1698-1702.
23. Elayan IM. Effect of hyperbaric oxygen treatment on nitric oxide and oxygen free radicals in rat brain. J Neurophysiol. 2000;83:2022-2029.
24. Ke X. Nitric oxide regulates actin reorganization through cGMP and Ca(2+)/calmodulin in RAW 264.7 cells. Biochim Biophys Acta 2001;1539:101-113.
25. Ellis S. The novel Rho-family GTPase rif regulates coordinated actin-based membrane rearrangements. Curr Biol. 2000;10:1387-1390.
26. Banick PD, Chen Q, Xu YA, Thom SR. Nitric oxide inhibits neutrophil beta 2 integrin function by inhibiting membraneassociated cyclicGMPsynthesis. J Cell Physiol. 1997;172:12-24.
27. Loitto VM, Nilsson H, Sundqvist T, Magnusson KE. Nitric oxide induces dose-dependent CA(2+) transients and causes temporal morphological hyperpolarization in human neutrophils. J Cell Physiol. 2000;182:402-413.
28. Janssen YM, Soultanakis R, Steece K, et al. Depletion of nitric oxide causes cell cycle alterations, apoptosis, and oxidative stress on pulmonary cells. Am J Physiol. 1998;275:L1100-L1109.
29. Akaike T, Yoshida M, Miyamoto Y, et al. Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/.NO through a radical reaction. Biochemistry 1993;32:827-832.
30. Salzman AL. Nitric oxide in the gut. New Horiz. 1995;3:33-45.
31. Frenkel SR, Clancy RM, Ricci JL, Di Cesare PE, Rediske JJ, Abramson SB. Effects of nitric oxide on chondrocytes migration, adhesion, and cytoskeletal assembly. Arthritis Rheum. 1996;39:1905-2012.
32. Staykova MA, Berven LA, Cowden WB, Willenborg DO, Crouch MF. Nitric oxide induces polarization of actin in encephalitogenic T cells and inhibits their in vitro transendothelial migration in a p70S6 kinase-independent manner. FASEB J. 2003;17:1337-1339.
33. Ingram AJ, James L, Cai L, Thai K, Ly H, Scholey JW. NO inhibits stretch-induced MAPK activity by cytoskeletal disruption. J Biol Chem. 2000;275:40301-40306.
34. Thom SR, Bhopale VM, Mancini DJ, Milovanova TN. Actin S-nitrosylation inhibits neutrophil B2 integrin function. J Biol Chem. 2008;283:10822-10834.
35. Thom SR. Effects of hyperoxia on neutrophil adhesion. Undersea Hyperb Med. 2004;31:123-131.
36. Maeda H, Akaike T, Yoshida M, Suga M. Multiple functions of nitric oxide in pathophysiology and microbiology: Analysis by a new nitric oxide scavenger. J Leukoc Biol. 1994;56:588-592.
37. Southan GJ, Szabó C. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol. 1996;51:383-394.
38. Boer R, Ulrich W-R, Klein T, Mirau B, Haas S, Baur I. The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes. Mol Pharmacol. 2000; 58:1026-1034.
39. Moore PK, Babbedge RC, Wallace P, Gaffen ZA, Hart SL. 7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br J Pharmacol. 1993;108:296-297.
40. Babbedge RC, Blad-Ward PA, Hart SL, Moore PK. Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles. Br J Pharmacol. 1993;110:225-228.
41. Garvey EP, Oplinger JA, Furfine ES. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitricoxide synthase in vitro and in vivo. J Biol Chem. 1997;272: 4959-4963.
42. Thomsen LL, Scott JM, Topley P, Knowles RG, Keerie AJ, Frend AJ. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: Studies with 1400W, a novel inhibitor. Cancer Res. 1997;57:3300-3304.
43. Calderwood DA, Shattil SJ, Ginsber MH. Integrins and actin filaments: Reciprocal regulation of cell adhesion and signaling. J Biol Chem. 2000;275:22607-22610.
44. Baynosa RC, Naig AL, Murphy PS, et al. The effect of hyperbaric oxygen on NOS activity and transcription in ischemia reperfusion injury. J Am Coll Surg. 2005;201:S57-S58.